Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John E. (Jack) Jr. Bailey Insider Profile
11 Followers
John E. (Jack) Jr. Bailey, President & CEO, Director at G1 Therapeutics, holds 0.00 shares in G1 Therapeutics (Ticker: GTHX).
John E. (Jack) Jr. Bailey G1 Therapeutics (GTHX)President & CEO, Director
G1 Therapeutics (GTHX)
President & CEO, Director
Ranked #19,424 out of 99,335 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+36.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
John E. (Jack) Jr. Bailey does not currently own shares as a corporate insider.
A breakdown of John E. (Jack) Jr. Bailey's holdings
Insider Roles
John E. (Jack) Jr. Bailey does not currently hold a role as a corporate insider.
Roles that John E. (Jack) Jr. Bailey holds in companies
Most Profitable Insider Trade
Stock:
G1 Therapeutics
(GTHX)
(GTHX)
Rating:Informative Sell
Date:Jan 05, 2022 - Jan 05, 2023
Return:+48.70%
The most profitable trade made by John E. (Jack) Jr. Bailey
John E. (Jack) Jr. Bailey's Trading History
List of latest transactions for each holding click on a transaction to see John E. (Jack) Jr. Bailey's performance on stock
You May Also Like
John E. (Jack) Jr. Bailey insider profile FAQ
What is the percentage of profitable transactions made by John E. (Jack) Jr. Bailey?
The percentage of profitable transactions made by John E. (Jack) Jr. Bailey is 100%.
What is the average return per transaction made by John E. (Jack) Jr. Bailey?
The average return per transaction made by John E. (Jack) Jr. Bailey is 36.90%.
What stocks does John E. (Jack) Jr. Bailey hold?
John E. (Jack) Jr. Bailey holds: GTHX stocks.
What was John E. (Jack) Jr. Bailey’s latest transaction?
John E. (Jack) Jr. Bailey latest transaction was an Uninformative Buy of ―.
What was John E. (Jack) Jr. Bailey's most profitable transaction?
John E. (Jack) Jr. Bailey’s most profitable transaction was an Informative Sell of GTHX stock on January 5, 2022. The return on the trade was 48.70%.
What is John E. (Jack) Jr. Bailey's role in G1 Therapeutics?
John E. (Jack) Jr. Bailey's role in G1 Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.